Immune responses to COVID-19 vaccination in people living with HIV
Learning Series
Zabrina Brumme, Ph.D. Laboratory Director, BC Centre for Excellence in HIV/AIDS Professor, Faculty of Health Sciences Simon Fraser University Scholar, Michael Smith Foundation for Health Research
The British Columbia Centre for Excellence in HIV/AIDS Laboratory has discontinued gp-41 resistance testing as T-20 (enfuvirtide/Fuzeon) is no longer available in Canada as of March 31, 2025